From molecule to market
SGS Life Science Service’s mission is to
safeguard the quality of medicines by'
providing professional and independent services
in clinical research and quality-control'
testing of pharmaceuticals, biopharmaceuticals
and medical devices, thereby creating value'
for its clients, employees and shareholders and
benefits for patients worldwide.
SGS has 35 years of experience as a global contract'
service organisation providing integrated solutions,
from'
preclinical activities to Phase I-IV trials, bioanalytical'
and quality control testing. With 1,300 employees,
cutting-edge'
clinical pharmacology units and the world’s
largest network'
of GMP-compliant laboratories, SGS serves the
pharma,'
biotechnology and medical device industries across
Europe,'
America and Asia, with 21 facilities located in
13 countries.
Thanks to its global presence and broad range
of services, it'
is often a preferred partner for the Top 20 pharmaceuticals
and'
biotechnology companies. The SGS strategy leverages
its'
network of international quality control testing
laboratories and'
clinical units and focuses on the pharmaceutical
development'
services from ‘preclinical development to
post-marketing’.
R&D Centre of Excellence for biologicals
SGS has developed an R&D Centre of Excellence
for biologics'
and vaccines in Europe. The analysis of biopharmaceuticals,
such'
as recombinant proteins and peptides, monoclonal
antibodies'
and nucleic acid-based drugs, requires different
skills from those'
of small chemical entities. Many analytical techniques,
such as'
LC/MS/MS, and capillary electrophoresis or real-time
RT-PCR,'
have emerged from an R&D setting into routine
operation.
Team up with SGS for your biological'
and vaccine development
- Fully integrated, specialised services from
molecule to'
market including:
- Lead qualification and optimisation
- Preclinical and clinical screening
- Regulatory intelligence and quality control
along'
the drug development process
- Expertise of SGS's laboratory network to facilitate'
global testing strategies implemented locally
- Strong geographic approach duplicates local'
successes globally
- Recognised first class biotech specialists.
Clinical and bioanalytical research services
The company is one of Europe’s largest First-In-Human'
pharmacology centres and bioanalytical service
providers. It has'
the expertise to develop complex trials supporting
screening'
or large-scale trials and analysis, from preclinical
and clinical'
studies – and to deliver them on time. Its
facilities include:
- Two Phase I centres in Europe (Paris and Antwerp):
184 beds
- Global clinical trial coordination: Phase
I-IV located in eight'
offices covering Europe (including CEE) and
the US'
- Two GLP bioanalytical laboratories in France
and Belgium.
Team up with SGS for your complete'
clinical development
- European leader in exploratory and pharmacology
trials
- Global expert in clinical trial management,
focusing on'
infectious diseases, CNS and cardiology
- Strong biometrics group: pioneer in use of
EDC systems'
for Phase I-IV; CDISC compliant
- Support of regulatory affairs and pharmacovigilance
services
- Largest European CRO in bioanalysis, featuring
mass'
spectrometry and immunoassays
R&D/QC services
With a harmonised network of 13 laboratories in
the'
US, Canada, Germany, France, Belgium, India, Thailand,'
Singapore, Taiwan and China, the R&D/QC Services'
Team provides regulatory-compliant (cGMP and/or
ISO)'
analytical services to its clients. All laboratories
have'
been inspected by local regulatory authorities
and, where'
applicable, the US-FDA or EMA. One global Quality'
Manual, harmonised SOPs and process flow, global
QA'
and a standardised LIMS system all ensure consistent'
high-quality services across all laboratories.
Team up with SGS for your R&D and QC testing
- Globally harmonised network of analytical
labs and'
consultancy in major markets
- Quality-control testing as the company’s
core'
competence
- Analyses performed under cGMP, GLP, ISO 17025
and'
ISO 9001
- Comprehensive breadth and depth of tests performed
in'
one source
- Industry-leading turnaround times.
With innovative study designs, an R&D center
of'
excellence, optimal facilities and strong regulatory'
intelligence, SGS can significantly help its clients
to:
- Ensure the quality, safety and effectiveness
of drugs
- Make the right go-no-go decisions
- Reduce time to market
Can you afford not to partner SGS?
|
 |
Company profile
SGS Life Science Services
For further information,
visit: www.sgs.com/lifescience
|
